Powder: -20°C for 3 years | In solvent: -80°C for 1 year
G15 是一种高亲和力的、选择性的 G 蛋白偶联雌激素受体(GPER/GPR30)拮抗剂(Ki:20 nM)。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
1 mg | ¥ 259 | 现货 | ||
5 mg | ¥ 586 | 现货 | ||
10 mg | ¥ 975 | 现货 | ||
25 mg | ¥ 1,870 | 现货 | ||
50 mg | ¥ 2,950 | 现货 | ||
100 mg | ¥ 4,350 | 现货 | ||
1 mL * 10 mM (in DMSO) | ¥ 649 | 现货 |
产品描述 | G15 is a cell-permeable non-steroidal antagonist of GPER (Ki = 20 nM) |
靶点活性 | GPER:20 nM(Ki) |
体内活性 | G-15 antagonizes the anti-depressive effects of estrogen in vivo[1]. |
动物实验 | G15 and G1 were first dissolved in DMSO and diluted with saline; the final concentration in DMSO was 1 mM. Desipramine and E2 (cyclodextrin-encapsulated, 4-5.5% E2) were dissolved in saline solution and DMSO was added to a final concentration of 1 mM. An appropriate vehicle-treated group (saline with 1 mM DMSO) was included as a control (sham). All solutions were freshly prepared before each experimental series. Independent groups of mice (n=12-16) were treated with two consecutive intraperitoneal injections as follows: vehicle solution + vehicle solution (sham group); vehicle + G-1 (indicated amount in nmol); vehicle + desipramine (10mg/kg); G15 (10nmol/mouse) + desipramine (10mg/kg); G15 (10nmol/mouse) + G-1 (1nmol/mouse); vehicle + G15 (10nmol/mouse); vehicle + soluble E2 (5 mg/kg); G15 (25nmol/mouse) + soluble E2 (5 mg/kg). The second compound was injected 15 min (7 min for E2) after the first injection and the tail suspension test performed 30 min after the second injection[1]. |
分子量 | 370.24 |
分子式 | C19H16BrNO2 |
CAS No. | 1161002-05-6 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 41.67 mg/mL (112.55 mM)
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
DMSO | 1 mM | 2.701 mL | 13.5048 mL | 27.0095 mL | 67.5238 mL |
5 mM | 0.5402 mL | 2.701 mL | 5.4019 mL | 13.5048 mL | |
10 mM | 0.2701 mL | 1.3505 mL | 2.701 mL | 6.7524 mL | |
20 mM | 0.135 mL | 0.6752 mL | 1.3505 mL | 3.3762 mL | |
50 mM | 0.054 mL | 0.2701 mL | 0.5402 mL | 1.3505 mL | |
100 mM | 0.027 mL | 0.135 mL | 0.2701 mL | 0.6752 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
G15 1161002-05-6 Endocrinology/Hormones Estrogen Receptor/ERR Inhibitor inhibit G-15 G 15 inhibitor